RECRUITING

Optical Coherence Tomography Angiography in Neurological Disease

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Optical Coherence Tomography Angiography (OCTA) is a non-invasive tool that images the neurovascular structures of the eye by using near-infrared light. Previous literature has demonstrated the potential of OCTA as a screening tool in stroke, but its utility in other neurological illness such as intracranial hemorrhage is unclear. Hence, this pilot study will gather preliminary data to support future grant applications to investigate this area more fully by recruiting patients with neurological illness and healthy controls and comparing their OCTA imaging parameters.

Official Title

Optical Coherence Tomography Angiography in Neurological Disease: a Pilot Study

Quick Facts

Study Start:2024-10-20
Study Completion:2025-10-20
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06797765

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Age 18 years or older
  2. * Patient admitted to the neuroscience intensive care unit with a diagnosis of: subarachnoid hemorrhage, intracerebral hemorrhage, intracranial aneurysm (ruptured or unruptured), intracranial vascular malformation, ischemic stroke, seizure disorder, intracranial infection, intracranial tumor(s), inflammatory demyelinating disease, traumatic brain injury and/or neuromuscular respiratory failure OR subjects from the community without major neurologic, cardiovascular, pulmonary or metabolic disease
  1. * Pregnancy
  2. * Non-English speaking
  3. * GCS motor score less than 6 (i.e. must be able to follow commands)
  4. * Temporary or permanent physical limitation that renders the patient unable to sit up and look inside OCTA device

Contacts and Locations

Study Contact

Noah Jouett, DO, PhD
CONTACT
214-645-7011
noah.jouett@utsouthwestern.edu
Emily Melikman, MBBS, RN
CONTACT
214-645-7011
emily.melikman@utsouthwestern.edu

Study Locations (Sites)

UT Southwestern Medical Center
Dallas, Texas, 75235
United States

Collaborators and Investigators

Sponsor: University of Texas Southwestern Medical Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-20
Study Completion Date2025-10-20

Study Record Updates

Study Start Date2024-10-20
Study Completion Date2025-10-20

Terms related to this study

Additional Relevant MeSH Terms

  • Octa
  • Stroke
  • Subarachnoid Hemorrhage
  • Intracerebral Hemorrhage